位置:首页 > 蛋白库 > AK3_ECOLI
AK3_ECOLI
ID   AK3_ECOLI               Reviewed;         449 AA.
AC   P08660; Q2M6T0;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1993, sequence version 2.
DT   03-AUG-2022, entry version 172.
DE   RecName: Full=Lysine-sensitive aspartokinase 3;
DE            EC=2.7.2.4 {ECO:0000269|PubMed:14623187};
DE   AltName: Full=Aspartate kinase III;
DE            Short=AKIII;
DE   AltName: Full=Lysine-sensitive aspartokinase III;
GN   Name=lysC; Synonyms=apk; OrderedLocusNames=b4024, JW3984;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 1-27.
RC   STRAIN=K12;
RX   PubMed=3003049; DOI=10.1016/s0021-9258(17)36051-9;
RA   Cassan M., Parsot C., Cohen G.N., Patte J.-C.;
RT   "Nucleotide sequence of lysC gene encoding the lysine-sensitive
RT   aspartokinase III of Escherichia coli K12. Evolutionary pathway leading to
RT   three isofunctional enzymes.";
RL   J. Biol. Chem. 261:1052-1057(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=8265357; DOI=10.1093/nar/21.23.5408;
RA   Blattner F.R., Burland V.D., Plunkett G. III, Sofia H.J., Daniels D.L.;
RT   "Analysis of the Escherichia coli genome. IV. DNA sequence of the region
RT   from 89.2 to 92.8 minutes.";
RL   Nucleic Acids Res. 21:5408-5417(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J., Mau B.,
RA   Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains MG1655
RT   and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-20.
RX   PubMed=6312411; DOI=10.1093/nar/11.18.6157;
RA   Cassan M., Ronceray J., Patte J.-C.;
RT   "Nucleotide sequence of the promoter region of the E. coli lysC gene.";
RL   Nucleic Acids Res. 11:6157-6166(1983).
RN   [6]
RP   SUBUNIT, INVOLVEMENT OF C-TERMINUS IN DIMERIZATION, MUTAGENESIS OF LYS-8;
RP   GLU-119; ARG-198 AND ASP-202, AND CATALYTIC ACTIVITY.
RX   PubMed=14623187; DOI=10.1016/j.jmb.2003.09.038;
RA   Marco-Marin C., Ramon-Maiques S., Tavarez S., Rubio V.;
RT   "Site-directed mutagenesis of Escherichia coli acetylglutamate kinase and
RT   aspartokinase III probes the catalytic and substrate-binding mechanisms of
RT   these amino acid kinase family enzymes and allows three-dimensional
RT   modelling of aspartokinase.";
RL   J. Mol. Biol. 334:459-476(2003).
RN   [7] {ECO:0007744|PDB:2J0W, ECO:0007744|PDB:2J0X}
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN COMPLEXES WITH ADP; ASPARTATE AND
RP   LYSINE INHIBITOR, SUBUNIT, AND ACTIVITY REGULATION.
RX   PubMed=16905770; DOI=10.1074/jbc.m605886200;
RA   Kotaka M., Ren J., Lockyer M., Hawkins A.R., Stammers D.K.;
RT   "Structures of R- and T-state Escherichia coli aspartokinase III.
RT   Mechanisms of the allosteric transition and inhibition by lysine.";
RL   J. Biol. Chem. 281:31544-31552(2006).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-aspartate = 4-phospho-L-aspartate + ADP;
CC         Xref=Rhea:RHEA:23776, ChEBI:CHEBI:29991, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:57535, ChEBI:CHEBI:456216; EC=2.7.2.4;
CC         Evidence={ECO:0000269|PubMed:14623187};
CC   -!- ACTIVITY REGULATION: Synthesis and activity are sensitive to the
CC       allosteric inhibitor lysine, one of the end metabolites of the aspartic
CC       acid family branched pathway. {ECO:0000269|PubMed:16905770}.
CC   -!- PATHWAY: Amino-acid biosynthesis; L-lysine biosynthesis via DAP
CC       pathway; (S)-tetrahydrodipicolinate from L-aspartate: step 1/4.
CC   -!- SUBUNIT: Homodimer. In the inactive form a homotetramer is formed.
CC       {ECO:0000269|PubMed:14623187, ECO:0000269|PubMed:16905770}.
CC   -!- MISCELLANEOUS: Aspartokinases I and II also catalyze the same
CC       reaction(s).
CC   -!- SIMILARITY: Belongs to the aspartokinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M11812; AAA24095.1; -; Genomic_DNA.
DR   EMBL; U00006; AAC43118.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76994.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE78026.1; -; Genomic_DNA.
DR   EMBL; X00008; CAA24910.1; -; Genomic_DNA.
DR   PIR; G65209; KIECD3.
DR   RefSeq; NP_418448.1; NC_000913.3.
DR   RefSeq; WP_001290310.1; NZ_SSZK01000049.1.
DR   PDB; 2J0W; X-ray; 2.50 A; A=1-449.
DR   PDB; 2J0X; X-ray; 2.80 A; A/B=1-449.
DR   PDBsum; 2J0W; -.
DR   PDBsum; 2J0X; -.
DR   AlphaFoldDB; P08660; -.
DR   PCDDB; P08660; -.
DR   SMR; P08660; -.
DR   BioGRID; 4261955; 8.
DR   STRING; 511145.b4024; -.
DR   jPOST; P08660; -.
DR   PaxDb; P08660; -.
DR   PRIDE; P08660; -.
DR   DNASU; 948531; -.
DR   EnsemblBacteria; AAC76994; AAC76994; b4024.
DR   EnsemblBacteria; BAE78026; BAE78026; BAE78026.
DR   GeneID; 948531; -.
DR   KEGG; ecj:JW3984; -.
DR   KEGG; eco:b4024; -.
DR   PATRIC; fig|1411691.4.peg.2689; -.
DR   EchoBASE; EB0545; -.
DR   eggNOG; COG0527; Bacteria.
DR   HOGENOM; CLU_009116_6_0_6; -.
DR   InParanoid; P08660; -.
DR   OMA; LMSCGEV; -.
DR   PhylomeDB; P08660; -.
DR   BioCyc; EcoCyc:ASPKINIII-MON; -.
DR   BioCyc; MetaCyc:ASPKINIII-MON; -.
DR   BRENDA; 2.7.2.4; 2026.
DR   SABIO-RK; P08660; -.
DR   UniPathway; UPA00034; UER00015.
DR   EvolutionaryTrace; P08660; -.
DR   PRO; PR:P08660; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0004072; F:aspartate kinase activity; IDA:EcoCyc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0009090; P:homoserine biosynthetic process; IDA:EcoCyc.
DR   GO; GO:0009089; P:lysine biosynthetic process via diaminopimelate; IDA:EcoCyc.
DR   GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW.
DR   CDD; cd04258; AAK_AKiii-LysC-EC; 1.
DR   Gene3D; 1.20.120.1320; -; 1.
DR   Gene3D; 3.40.1160.10; -; 1.
DR   InterPro; IPR036393; AceGlu_kinase-like_sf.
DR   InterPro; IPR045865; ACT-like_dom_sf.
DR   InterPro; IPR002912; ACT_dom.
DR   InterPro; IPR041745; AKiii-LysC-EC.
DR   InterPro; IPR001048; Asp/Glu/Uridylate_kinase.
DR   InterPro; IPR005260; Asp_kin_monofn.
DR   InterPro; IPR001341; Asp_kinase.
DR   InterPro; IPR042199; AsparK_Bifunc_asparK/hSer_DH.
DR   InterPro; IPR018042; Aspartate_kinase_CS.
DR   Pfam; PF00696; AA_kinase; 1.
DR   Pfam; PF01842; ACT; 1.
DR   PIRSF; PIRSF000726; Asp_kin; 1.
DR   SUPFAM; SSF53633; SSF53633; 1.
DR   SUPFAM; SSF55021; SSF55021; 2.
DR   TIGRFAMs; TIGR00656; asp_kin_monofn; 1.
DR   TIGRFAMs; TIGR00657; asp_kinases; 1.
DR   PROSITE; PS51671; ACT; 1.
DR   PROSITE; PS00324; ASPARTOKINASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Allosteric enzyme; Amino-acid biosynthesis; ATP-binding;
KW   Direct protein sequencing; Kinase; Lysine biosynthesis; Nucleotide-binding;
KW   Reference proteome; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT   CHAIN           2..449
FT                   /note="Lysine-sensitive aspartokinase 3"
FT                   /id="PRO_0000066676"
FT   DOMAIN          313..394
FT                   /note="ACT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01007"
FT   REGION          2..245
FT                   /note="Aspartokinase"
FT   REGION          246..449
FT                   /note="Interface"
FT   REGION          299..449
FT                   /note="Required for homodimerization"
FT   BINDING         8..11
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         45
FT                   /ligand="substrate"
FT   BINDING         119
FT                   /ligand="substrate"
FT   BINDING         198..201
FT                   /ligand="substrate"
FT   BINDING         221..222
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         227
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         232
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         257..258
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT   BINDING         318
FT                   /ligand="L-lysine"
FT                   /ligand_id="ChEBI:CHEBI:32551"
FT                   /ligand_note="allosteric inhibitor; ligand shared between
FT                   homodimeric partners"
FT                   /evidence="ECO:0007744|PDB:2J0X"
FT   BINDING         321
FT                   /ligand="L-lysine"
FT                   /ligand_id="ChEBI:CHEBI:32551"
FT                   /ligand_note="allosteric inhibitor; ligand shared between
FT                   homodimeric partners"
FT                   /evidence="ECO:0007744|PDB:2J0X"
FT   BINDING         324..325
FT                   /ligand="L-lysine"
FT                   /ligand_id="ChEBI:CHEBI:32551"
FT                   /ligand_note="allosteric inhibitor; ligand shared between
FT                   homodimeric partners"
FT                   /evidence="ECO:0007744|PDB:2J0X"
FT   BINDING         338..340
FT                   /ligand="L-lysine"
FT                   /ligand_id="ChEBI:CHEBI:32551"
FT                   /ligand_note="allosteric inhibitor; ligand shared between
FT                   homodimeric partners"
FT                   /evidence="ECO:0007744|PDB:2J0X"
FT   BINDING         345..346
FT                   /ligand="L-lysine"
FT                   /ligand_id="ChEBI:CHEBI:32551"
FT                   /ligand_note="allosteric inhibitor; ligand shared between
FT                   homodimeric partners"
FT                   /evidence="ECO:0007744|PDB:2J0X"
FT   MUTAGEN         8
FT                   /note="K->R: Reduces activity about 98%. Increases KM for
FT                   aspartate about 40-fold, enzyme is less sensitive to lysine
FT                   inhibition."
FT                   /evidence="ECO:0000269|PubMed:14623187"
FT   MUTAGEN         119
FT                   /note="E->D: Increases KM for aspartate about 3000-fold."
FT                   /evidence="ECO:0000269|PubMed:14623187"
FT   MUTAGEN         198
FT                   /note="R->K: Increases KM for aspartate about 200-fold."
FT                   /evidence="ECO:0000269|PubMed:14623187"
FT   MUTAGEN         202
FT                   /note="D->E: Reduces activity about 98%. Increases KM for
FT                   aspartate about 40-fold, enzyme is less sensitive to lysine
FT                   inhibition."
FT                   /evidence="ECO:0000269|PubMed:14623187"
FT   CONFLICT        14..15
FT                   /note="VA -> AS (in Ref. 5; CAA24910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        20
FT                   /note="M -> E (in Ref. 5; CAA24910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        58
FT                   /note="G -> C (in Ref. 1; AAA24095)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        401
FT                   /note="G -> A (in Ref. 1; AAA24095)"
FT                   /evidence="ECO:0000305"
FT   STRAND          5..9
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           12..14
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           17..27
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   STRAND          33..38
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           44..51
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           57..75
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   STRAND          78..80
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           82..102
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           108..131
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   TURN            132..134
FT                   /evidence="ECO:0007829|PDB:2J0X"
FT   STRAND          137..139
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           142..144
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           159..169
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           171..176
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   STRAND          177..187
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   STRAND          193..195
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           200..211
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   STRAND          215..229
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   TURN            231..233
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   STRAND          239..244
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           245..253
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   TURN            261..263
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           264..270
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   STRAND          274..280
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           282..284
FT                   /evidence="ECO:0007829|PDB:2J0X"
FT   STRAND          287..291
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   STRAND          298..313
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           316..318
FT                   /evidence="ECO:0007829|PDB:2J0X"
FT   HELIX           321..328
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   TURN            329..336
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   STRAND          340..345
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   STRAND          348..353
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           368..377
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   STRAND          380..395
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   STRAND          399..401
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           402..407
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           408..410
FT                   /evidence="ECO:0007829|PDB:2J0X"
FT   STRAND          417..419
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   STRAND          426..432
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           433..435
FT                   /evidence="ECO:0007829|PDB:2J0W"
FT   HELIX           436..448
FT                   /evidence="ECO:0007829|PDB:2J0W"
SQ   SEQUENCE   449 AA;  48532 MW;  5B41CE3A6E4D984B CRC64;
     MSEIVVSKFG GTSVADFDAM NRSADIVLSD ANVRLVVLSA SAGITNLLVA LAEGLEPGER
     FEKLDAIRNI QFAILERLRY PNVIREEIER LLENITVLAE AAALATSPAL TDELVSHGEL
     MSTLLFVEIL RERDVQAQWF DVRKVMRTND RFGRAEPDIA ALAELAALQL LPRLNEGLVI
     TQGFIGSENK GRTTTLGRGG SDYTAALLAE ALHASRVDIW TDVPGIYTTD PRVVSAAKRI
     DEIAFAEAAE MATFGAKVLH PATLLPAVRS DIPVFVGSSK DPRAGGTLVC NKTENPPLFR
     ALALRRNQTL LTLHSLNMLH SRGFLAEVFG ILARHNISVD LITTSEVSVA LTLDTTGSTS
     TGDTLLTQSL LMELSALCRV EVEEGLALVA LIGNDLSKAC GVGKEVFGVL EPFNIRMICY
     GASSHNLCFL VPGEDAEQVV QKLHSNLFE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024